Crystal and Molecular Structure of Perphenazine {2-Chloro-10-(3-[4-(2-hydroxyethyl)-piperazin-1-yl) propyl phenothiazine}: Conformational Variabilities of the Phenothiazine Ring

被引：0
|
作者：
Andrew J. Lyle
Christopher Wood
Thamarapu Srikrishnan
机构：
[1] Roswell Park Cancer Institute,Department of Cancer Biology
来源：
Journal of Chemical Crystallography | 2008年 / 38卷
关键词：
Crystal structure; Perphenazine; Structure–function relationship in phenothiazine ring systems; Antimetic drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：261 / 265
页数：4
相关论文
共 50 条
  • [21] SYNTHESIS, CRYSTAL STRUCTURE, AND BIOLOGICAL EVALUATION OF (E)-1-(4-(4-BROMOBENZYL)PIPERAZIN-1-YL)- 3-(4-CHLOROPHENYL)PROP-2-EN-1-ONE
    L. -Y. Chen
    C. -Z. Yang
    Y. Xu
    C. -Y. Qi
    Y. Zhong
    B. Wu
    Journal of Structural Chemistry, 2021, 62 : 481 - 490
  • [22] SYNTHESIS, CRYSTAL STRUCTURE, AND BIOLOGICAL EVALUATION OF (E)-1-(4-(4-BROMOBENZYL)PIPERAZIN-1-YL)- 3-(4-CHLOROPHENYL)PROP-2-EN-1-ONE
    Chen, L. -Y.
    Yang, C. -Z.
    Xu, Y.
    Qi, C. -Y.
    Zhong, Y.
    Wu, B.
    JOURNAL OF STRUCTURAL CHEMISTRY, 2021, 62 (03) : 481 - 490
  • [23] Synthesis,Crystal Structure and Biological Activity of 1-(4-(4-Ethoxybenzyl)piperazin-1-yl)-2-(2-methylphenoxy)ethanone
    李小凤
    陈晓宏
    仲琰
    许逸
    李萍
    吴斌
    结构化学, 2017, 36 (12) : 2027 - 2032
  • [24] Synthesis,Crystal Structure and Neuroprotection of Methyl 2-((4-(2-(2-Methylphenoxy)acetyl)-piperazin-1-yl)-methyl)benzoate
    仲琰
    王垚
    王晶
    许逸
    李萍
    吴斌
    结构化学, 2014, 33 (07) : 1096 - 1101
  • [25] Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist
    Magdalena Kotańska
    Katarzyna Kulig
    Monika Marcinkowska
    Marek Bednarski
    Katarzyna Malawska
    Paula Zaręba
    Journal of Endocrinological Investigation, 2018, 41 : 609 - 619
  • [26] Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist
    Kotanska, Magdalena
    Kulig, Katarzyna
    Marcinkowska, Monika
    Bednarski, Marek
    Malawska, Katarzyna
    Zareba, Paula
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (05) : 609 - 619
  • [27] Design, Synthesis and 5-HT1A Binding Affinity of N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)tricyclo[3.3.1.13,7]decan-1-amine and N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[3.3.1.13,7]decan-1-amine
    Zoidis, Grigoris
    Isabel Loza, Maria
    Catto, Marco
    MOLBANK, 2022, 2022 (01)
  • [28] PHARMACOLOGICAL STUDIES ON TRIAZINE DERIVATIVES .5. SEDATIVE AND NEUROLEPTIC ACTIONS OF 2-AMINO-4-[4-(2-HYDROXYETHYL)-PIPERAZIN-1-YL]-6-TRIFLUOROMETHYL-S-TRIAZINE (TR-10)
    TOBE, A
    KOBAYASHI, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1976, 26 (05): : 559 - 570
  • [29] 1-[1-(4-Chlorobenzenesulfonyl)-1H-indole-3-yl]-3-[4-(pyridin-2-yl)piperazin-1-yl]propan-1-one
    Diethelm, Benjamin
    Almendras, Sebastian
    Recabarren-Gajardo, Gonzalo
    MOLBANK, 2018, (02)
  • [30] Crystal structure of 3-(2-chloro-benzyl)-7-[4-(2-chloro-benzyl)-piperazin-1-yl]-5,6,8-trifluoro-3H-quinazolin-4-one, C26H21Cl2F3N4O
    Fang, Shu-Fen
    Peng, Wen-Wen
    Xiong, Yuan-Zhen
    Nie, Xu-Liang
    Huang, Jian-Ping
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2021, 236 (04): : 815 - 817
12345